Zolpidem Catatonia Case Found Initial Improvement With Limited Durability

A transient response after unsuccessful benzodiazepine treatment did not establish sustained benefit from zolpidem.

What the supplied paper reports

A twenty-five-year-old woman with schizophrenia and severe catatonia had limited response to benzodiazepine therapy and could not pursue ECT. A zolpidem challenge and subsequent divided dosing were followed by partial improvements in speech, alertness and participation. Later sedation and diminishing benefit ultimately limited continued treatment.

What the findings cannot establish

This was an uncontrolled case with substantial psychiatric complexity and concurrent medicines. Initial improvement cannot establish superiority over an adequately characterized alternative treatment. Durability, tolerability and functional benefit are distinct outcomes; a briefly favorable observation does not establish long-term recovery.

Implications for forensic review

For review of a claimed paradoxical response, track the exact target behavior and its duration after each administration. Separate increased engagement from simple changes in wakefulness. The case illustrates both a possible symptomatic response and why adverse sedation and loss of effect must remain part of the reported outcome.

Source and related reading

Source reviewed: Efficacy of Zolpidem Tartrate in Benzodiazepine Refractory Catatonia A Case Report (PMC13040616). The forensic applications above are interpretive analysis of the supplied paper.

Related reading: Lorazepam Improvement in Wilson’s Disease Catatonia Did Not Replace the Copper-Metabolism Diagnosis.